• Ep 25 - John Robson - True Venture Capital vs. Vulture Capital

  • May 26 2024
  • Duración: 57 m
  • Podcast

Ep 25 - John Robson - True Venture Capital vs. Vulture Capital

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Today’s guest is John Robson (JR), General Manager at Bridgewest Ventures NZ, and Managing Director of BioOra, a company that is automating the manufacture of CAR T-cells.

    This episode is brought to you by SAPRO Consulting: https://www.saproconsulting.com.au/

    The development of new technologies, whether it be medical or otherwise, requires a lot of resources. One of those resources is capital - financial capital. Financial capital for new ventures can come in many forms, including loans from Mom & Pop or the bank, angel investment, grants, or private capital.

    One of the forms of private capital is venture capital, or VC. VC is characterised by investment in young companies with growth potential. But it's not just about the money. As JR puts it, no founder has every said they were successful because they had an endless supply of money...

    In this episode, and I discuss:
    1. The idiosyncrasies of the New Zealand start-up ecosystem
    2. Venture Capital's role to play in the ecosystem
    3. Bridgwest's portfolio of companies working in the CAR space
    ....and much much more.

    You can find out more about John Robson and Bridgewest Ventures here:
    LinkedIn - John Robson (JR)
    LinkedIn - Bridgewest Ventures
    https://bridgewest.ventures/
    https://bioora.com/

    Timestamps:
    00:00 Teaser
    00:30 Introduction
    02:20 True Venture Capital vs. Vulture Capital
    05:00 Early Stage / Deep Tech Investment
    09:20 Improving the status quo - Infrastructure, Human Capital, Regulation
    16:00 Money follows success
    20:33 Shaping the world around you
    23:15 Doing more with less
    25:20 It's not just about the money
    26:10 Celebrating, and advertising, our successes
    29:45 Where does the money come from - Bridgewest edition
    34:30 Industry average is one in ten companies
    36:20 Early VC - TechTransfer Office involvement
    40:00 Founder Equity - Bespoke arrangements
    44:00 Bridgewest's CAR portfolio companies
    53:15 Advice for Biotech entrepreneurs

    To get in touch head to: https://www.instagram.com/_good_clinical/

    Vulture Capital vs. True Venture Capital | John Robson | Ep 25
    #goodclinical #goodclinicalpodcast #goodclinicalexplains #goodclinicalevents #goodclinicalnetwork #innovation #podcast #newzealand #commercialization #venturecapital #vc #clinicalresearchassociate #technologytransfer #biotech #science #choices #country #entrepreneur #products #clinicalresearch #biotech #clinicalpractice #chatgcp #healthcare #clinicaltrials #medicine #humanhealth
    Más Menos
Enfermedades Físicas Hygiene & Healthy Living Política y Gobierno Ciencias Biológicas
Más Menos

Lo que los oyentes dicen sobre Ep 25 - John Robson - True Venture Capital vs. Vulture Capital

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles